Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
1991-7-19
pubmed:databankReference
pubmed:abstractText
Decay-accelerating factor (DAF) expression modulates susceptibility of cells to autologous complement attack. To characterize the regulatory region controlling DAF gene transcription, genomic DNA extending from 815 base pairs (bp) upstream to approximately 4 kilobases downstream of DAF's AUG codon (designated +1) was cloned and sequenced. The 5' flanking sequence showed 59-76% G + C content (-355 to +1), at least one GC box(es) (-135 to -131), and variable length sequences (from -629 to -285) conforming to the motifs TCCTCC and TCn. Nuclease S1 digestions and primer extensions localized a major transcriptional start site to -82/-81, 38 bp downstream of a possible TATA variant, (A)TTTAA. In COS cell transfections, the sequence encompassing -815 to -67 functioned 2.5% as efficiently as the Rous sarcoma virus 3' long terminal repeat, but following deletion upstream of -355 its activity increased approximately 4-fold. Two octanucleotides exhibiting partial homology to phorbol 12-myristate 13-acetate (PMA) and cAMP responsive elements (PREs and CREs, respectively) were detected, and the respective modulators enhanced transcriptional efficiency 2- and approximately 10-fold, respectively. Thus, the DAF gene promoter (i) exhibits sequences resembling both conventional and unconventional transcriptional control elements, (ii) possesses a region with negative regulatory activity, and (iii) responds to PMA and cAMP induction presumably via PRE- and CRE-like enhancer elements.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/1711208-1688581, http://linkedlifedata.com/resource/pubmed/commentcorrection/1711208-1688584, http://linkedlifedata.com/resource/pubmed/commentcorrection/1711208-1693916, http://linkedlifedata.com/resource/pubmed/commentcorrection/1711208-2431284, http://linkedlifedata.com/resource/pubmed/commentcorrection/1711208-2432921, http://linkedlifedata.com/resource/pubmed/commentcorrection/1711208-2433596, http://linkedlifedata.com/resource/pubmed/commentcorrection/1711208-2436222, http://linkedlifedata.com/resource/pubmed/commentcorrection/1711208-2436226, http://linkedlifedata.com/resource/pubmed/commentcorrection/1711208-2438369, http://linkedlifedata.com/resource/pubmed/commentcorrection/1711208-2448783, http://linkedlifedata.com/resource/pubmed/commentcorrection/1711208-2450893, http://linkedlifedata.com/resource/pubmed/commentcorrection/1711208-2464030, http://linkedlifedata.com/resource/pubmed/commentcorrection/1711208-2471198, http://linkedlifedata.com/resource/pubmed/commentcorrection/1711208-2474572, http://linkedlifedata.com/resource/pubmed/commentcorrection/1711208-2478749, http://linkedlifedata.com/resource/pubmed/commentcorrection/1711208-2665442, http://linkedlifedata.com/resource/pubmed/commentcorrection/1711208-271968, http://linkedlifedata.com/resource/pubmed/commentcorrection/1711208-2788607, http://linkedlifedata.com/resource/pubmed/commentcorrection/1711208-2833511, http://linkedlifedata.com/resource/pubmed/commentcorrection/1711208-3010279, http://linkedlifedata.com/resource/pubmed/commentcorrection/1711208-3023918, http://linkedlifedata.com/resource/pubmed/commentcorrection/1711208-3037355, http://linkedlifedata.com/resource/pubmed/commentcorrection/1711208-3464954, http://linkedlifedata.com/resource/pubmed/commentcorrection/1711208-3472230, http://linkedlifedata.com/resource/pubmed/commentcorrection/1711208-3665875, http://linkedlifedata.com/resource/pubmed/commentcorrection/1711208-390403, http://linkedlifedata.com/resource/pubmed/commentcorrection/1711208-6088070, http://linkedlifedata.com/resource/pubmed/commentcorrection/1711208-6586101, http://linkedlifedata.com/resource/pubmed/commentcorrection/1711208-6960240, http://linkedlifedata.com/resource/pubmed/commentcorrection/1711208-922889
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0027-8424
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
88
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
4675-9
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed-meshheading:1711208-Amino Acid Sequence, pubmed-meshheading:1711208-Antigens, CD55, pubmed-meshheading:1711208-Base Sequence, pubmed-meshheading:1711208-Blotting, Southern, pubmed-meshheading:1711208-Chromosome Deletion, pubmed-meshheading:1711208-Chromosomes, Human, Pair 1, pubmed-meshheading:1711208-Cloning, Molecular, pubmed-meshheading:1711208-Complement Inactivator Proteins, pubmed-meshheading:1711208-Escherichia coli, pubmed-meshheading:1711208-Gene Library, pubmed-meshheading:1711208-Humans, pubmed-meshheading:1711208-Membrane Proteins, pubmed-meshheading:1711208-Molecular Sequence Data, pubmed-meshheading:1711208-Oligonucleotide Probes, pubmed-meshheading:1711208-Promoter Regions, Genetic, pubmed-meshheading:1711208-Restriction Mapping, pubmed-meshheading:1711208-Sequence Homology, Nucleic Acid, pubmed-meshheading:1711208-Transfection
pubmed:year
1991
pubmed:articleTitle
Characterization of the decay-accelerating factor gene promoter region.
pubmed:affiliation
Institute of Pathology, Case Western Reserve University, Cleveland, OH 44106.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't